Koers Zhejiang Xinguang Pharmaceutical Co., Ltd.
Aandelen
300519
CNE1000027T3
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,13 CNY | +1,17% | +4,75% | -26,80% |
Omzet 2022 | 351 mln. 48,51 mln. 45,37 mln. | Omzet 2023 | 270 mln. 37,32 mln. 34,9 mln. | Marktkapitalisatie | 2,65 mld. 366 mln. 342 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 109 mln. 15,04 mln. 14,07 mln. | Nettowinst (verlies) 2023 | 64 mln. 8,83 mln. 8,26 mln. | EV/omzet 2022 | 5,03 x |
Nettoliquiditeiten 2022 | 737 mln. 102 mln. 95,13 mln. | Nettoliquiditeiten 2023 | 699 mln. 96,46 mln. 90,22 mln. | EV/omzet 2023 | 7,22 x |
K/w-verhouding 2022 |
23
x | K/w-verhouding 2023 |
41,4
x | Werknemers | 308 |
Dividendrendement 2022 |
3,19% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 42,17% |
1 dag | +1,17% | ||
1 week | +4,75% | ||
Lopende maand | -5,68% | ||
1 maand | -7,69% | ||
3 maanden | -17,43% | ||
6 maanden | -23,23% | ||
Lopend jaar | -26,80% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yue Jun Wang
CEO | Chief Executive Officer | 70 | 01-01-98 |
Bin Bin Xing
DFI | Director of Finance/CFO | 49 | 01-01-03 |
Zhu Ping Sun
CHM | Chairman | 61 | 18-11-98 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hu Gen Wang
BRD | Director/Board Member | 75 | 24-08-18 |
Yue Jun Wang
CEO | Chief Executive Officer | 70 | 01-01-98 |
Fu Yin Qiu
BRD | Director/Board Member | 62 | 01-01-01 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 12,13 | +1,17% | 1 833 500 |
25-04-24 | 11,99 | +1,27% | 1 752 600 |
24-04-24 | 11,84 | +1,28% | 1 293 700 |
23-04-24 | 11,69 | +1,65% | 1 432 900 |
22-04-24 | 11,5 | -0,69% | 1 310 900 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,80% | 268 mln. | |
+19,62% | 43,34 mld. | |
+20,44% | 21,96 mld. | |
+10,86% | 14,09 mld. | |
+13,07% | 13,64 mld. | |
+37,46% | 11,43 mld. | |
-8,59% | 6,86 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+8,46% | 5,22 mld. |